Parallel Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-144
Closed -$1.69K 3914
2025
Q4
$1.69K Hold
144
﹤0.01% 3170
2025
Q3
$1.11K Hold
144
﹤0.01% 3196
2025
Q2
$1.05K Sell
144
-96
-40% -$775 ﹤0.01% 3185
2025
Q1
$2.3K Buy
240
+64
+36% +$799 ﹤0.01% 2936
2024
Q4
$2.9K Hold
176
﹤0.01% 2837
2024
Q3
$2.6K Hold
176
﹤0.01% 2818
2024
Q2
$2.44K Sell
176
-29
-14% -$411 ﹤0.01% 2756
2024
Q1
$3.22K Hold
205
﹤0.01% 2663
2023
Q4
$3.32K Hold
205
﹤0.01% 2646
2023
Q3
$2.52K Hold
205
﹤0.01% 2742
2023
Q2
$3.29K Sell
205
-44
-18% -$725 ﹤0.01% 2579
2023
Q1
$4.33K Hold
249
﹤0.01% 2462
2022
Q4
$2.3K Buy
249
+3
+1% +$28 ﹤0.01% 2630
2022
Q3
$2K Sell
246
-57
-19% -$566 ﹤0.01% 2701
2022
Q2
$2K Sell
303
-4
-1% -$38 ﹤0.01% 2603
2022
Q1
$4K Buy
307
+237
+339% +$4.99K ﹤0.01% 2386
2021
Q4
$2K Sell
70
-983
-93% -$38.5K ﹤0.01% 2727
2021
Q3
$51K Buy
1,053
+1,044
+11,600% +$48.3K ﹤0.01% 1277
2021
Q2
$0 Sell
9
-23
-72% -$1.02K ﹤0.01% 3016
2021
Q1
$2K Buy
+32
New +$1.67K ﹤0.01% 2492

Other funds holding NEO

Parallel Advisors's NEO Position: Q1 2026 in Review

Parallel Advisors sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 144 shares — an estimated $1.69K sold.

Parallel Advisors first reported a position in NEO in Q1 2021 and held it in 20 quarters. The position peaked at $51K in Q3 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Parallel Advisors reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Parallel Advisors sold 144 NeoGenomics shares in Q1 2026, an estimated $1.69K.
  • Parallel Advisors first reported a position in NeoGenomics in Q1 2021 and held it in 20 quarters.
  • Parallel Advisors's NeoGenomics position peaked at $51K in Q3 2021.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.